Pharmacogenomics of Cardiovascular Pharmacology: Pharmacogenomic Network of Cardiovascular Disease Models
The most important strategies in pharmacogenomics are gene expression profiling and the network analysis of human disease models. We have previously discovered novel drug target candidates in cardiovascular diseases through investigations of these pharmacogenomics. The significant induction of S100C...
Saved in:
Main Authors: | Toshio Tanaka (Author), Takehiko Oka (Author), Yasuhito Shimada (Author), Noriko Umemoto (Author), Junya Kuroyanagi (Author), Chikara Sakamoto (Author), Liqing Zang (Author), Zhipeng Wang (Author), Yuhei Nishimura (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2008-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing
by: Callan Russell, et al.
Published: (2024) -
Cardiovascular precision medicine - A pharmacogenomic perspective
by: Sandosh Padmanabhan, et al.
Published: (2023) -
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
by: Christopher Barone, et al.
Published: (2009) -
Pharmacogenomics of Cardiovascular Pharmacology: Molecular Network Analysis in Pleiotropic Effects of Statin - an Experimental Elucidation of the Pharmacologic Action From Protein-Protein Interaction Analysis
by: Masayuki Shiota, et al.
Published: (2008) -
Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
by: Yong-Jian Geng, et al.
Published: (2021)